Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine
- Status
- COMPLETED
- Phase
- PHASE3
PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
- Status
- COMPLETED
- Phase
- PHASE2
Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients
- Status
- COMPLETED
- Phase
- PHASE3
Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of Pancreascarcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
- Status
- COMPLETED
- Phase
- PHASE3
HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Assess the Pharmacokinetics, Efficacy, and Safety of Atezolizumab Administered Intravenously (IV) as a Single Agent or in Combination With Chemotherapy in Chinese Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
- Status
- COMPLETED
- Phase
- PHASE3